Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name NKILA
   Synonyms AK056098
   Region GRCh38_20:57710183-57712780    Sequence
   Ensembl ENSG00000278709
   RefSeq NR_131157
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name malignant melanoma
   ICD-0-3  M8720/3
   Methods qPCR, RNAi, Western blot, Flow cytometry assay, Cell proliferation assay etc.
   Sample melanoma tissues, cell lines (M21, B16, MEL-RM, MM200, A375 and A2058)
   Expression Pattern down-regulated
   Function Description

NKILA was expressed at low levels in human melanoma tissues. Our results also indicated that NKILA inhibited the progression of cell proliferation, migration, and invasion, and promoted apoptosis of melanoma cells. Furthermore, qRT-PCR showed that NF-kB, which was negatively correlated with NKILA, was highly expressed in human melanoma tissues. Moreover, our results indicated that NKILA inhibited the carcinogenesis of melanoma cells through the inhibition of NF-B in vitro. More importantly, we found that NKILA suppressed the growth of melanoma tumors via NF-B in vivo.

   Pubmed ID 28123845
   Year 2017
   Title The long non-coding RNA NKILA inhibits the invasion-metastasis cascade of malignant melanoma via the regulation of NF-B.
   External Links
   Links for  NKILA GenBank       HGNC       lncrnadb       Noncode
   Links for  malignant melanoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.